Canakinumab for Childhood Sight-threatening Refractory Uveitis: A Case Series

J Rheumatol. 2016 Jul;43(7):1445-7. doi: 10.3899/jrheum.160064.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adalimumab / therapeutic use
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Child
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Humans
  • Infliximab / therapeutic use
  • Male
  • Methotrexate / therapeutic use
  • Recurrence
  • Risk Assessment
  • Severity of Illness Index
  • Tomography, Optical Coherence / methods
  • Treatment Outcome
  • Uveitis / diagnostic imaging*
  • Uveitis / drug therapy*
  • Vision Disorders / prevention & control*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • canakinumab
  • Infliximab
  • Adalimumab
  • Methotrexate